GlassScriptPhysician profile
Ji Yeon Kwon
NPI 1912492216
$4,413.53
in general payments reported to CMS, 2019-2025
17 companies · $958 in 2025
The $958 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.43 · 2022: $453 · 2023: $464 · 2024: $2,494 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,767 · Travel and Lodging: $1,749 · Education: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.92 |
| Travel and Lodging | $1,749.06 |
| Education | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,249.06 | 2024-2025 | |
| Davol INC. | $279.45 | 2022-2025 | Progel Applicator Spray Tips |
| Mayne Pharma Commercial LLC | $245.65 | 2023-2024 | |
| Atricure, INC. | $192.63 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $162.04 | 2022-2023 | Andexxa |
| Medtronic, INC. | $153.25 | 2025 | Signia |
| Seagen INC. | $149.68 | 2022 | |
| Galderma Laboratories, L.P. | $139.54 | 2025 | Nemluvio |
| Edwards Lifesciences Corporation | $136.55 | 2025 | Sapien 3 Ultra Resilia |
| Neurelis, INC. | $134.34 | 2025 | Valtoco |
| Genzyme Corporation | $124.83 | 2024 | |
| Averitas Pharma INC. | $121.82 | 2024 | Qutenza |
| Hologic Sales and Service, LLC | $104.92 | 2024 | Aptima |
| Scynexis, INC. | $87.07 | 2022 | |
| Myriad Genetic Laboratories, INC. | $60.62 | 2023 | Precisetumor |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $44.43 | 2021 | |
| Ethicon US, LLC | $27.65 | 2024 | N/A, Surgiflo Hemostatic Matrix, Harmonic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ji Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.